Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Giorgia Giussani

Istituto di Ricerche Farmacologiche Mario Negri IRCCS

Italy

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Neurology

50%

Neuropsychology

20%

Clinical Neurophysiology

40%

Nutritional Epidemiology

20%

Geriatric

20%

Neuroprotection

20%

Neuropathology

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Rapid versus slow withdrawal of antiepileptic monotherapy in two-year seizure-free adults patients with epilepsy (RASLOW) study: a pragmatic multicenter, prospective, randomized, controlled study Reply to letter to the editor

Article Link

Year:

2023

Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial

Article Link

Year:

2023

Sudden unexpected death in epilepsy: A critical view of the literature.

Article Link

Year:

2023

The epidemiology of epilepsy in older adults: A narrative review by the ILAE Task Force on Epilepsy in the Elderly.

Article Link

Year:

2023

Erratum to ‘In memoriam: Ettore Beghi’ [Seizure Volume 104, January 2023, Page 38] (Seizure: European Journal of Epilepsy (2023) 104 (38), (S105913112200276X), (10.1016/j.seizure.2022.11.015))

Article Link

Year:

2023

Global, regional, and national burden of diseases and injuries for adults 70 years and older

Article Link

Year:

2022

In memoriam: Ettore Beghi.

Article Link

Year:

2022

Management of epilepsy in older adults: A critical review by the ILAE Task Force on Epilepsy in the elderly.

Article Link

Year:

2022

Rapid versus slow withdrawal of antiepileptic monotherapy in two-year seizure-free adults patients with epilepsy (RASLOW) study: A pragmatic multicentre, prospective, randomized, controlled study.

Article Link

Year:

2022

Survey on the worldwide availability and affordability of antiseizure medications: Report of the ILAE Task Force on Access to Treatment.

Article Link

Year:

2022

Collaborators18

Tomasz Miazgowski

Pomeranian Medical University

POLAND

Zubair Kabir

University College Cork

IRELAND

Omid Shafaat

Hospital of the University of Pennsylvania

UNITED STATES

Elisa Bianchi

Mario Negri Institute for pharmacological research

ITALY

Silvia Schiavolin

Fondazione IRCCS Istituto Neurologico Carlo Besta

ITALY

Gianni Sorarù

Associate Professor

University of Padua

ITALY

Atte Meretoja

University of Helsinki

FINLAND

Parnaz Daneshpajouhnejad

Johns Hopkins University School of Medicine

UNITED STATES

Loretta Piccenna

MONASH UNIVERSITY

AUSTRALIA

Claudia Ricci

University of Siena

ITALY

Federico Vigevano

Head

Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea Polo Scientifico di Conegliano-Pieve di Soligo

ITALY

Elisabetta Pupillo

Head of Epidemiology of neurodegenerative disease Unit

Istituto di Ricerche Farmacologiche Mario Negri

ITALY

Umberto AGUGLIA

Professore Ordinario Neurologia

Università degli Studi Mediterranea di Reggio Calabria

ITALY

Naoki Akamatsu

Professor

International University of Health and Welfare

JAPAN

Jacopo C. DiFrancesco

University of Milano-Bicocca

ITALY

Giancarlo Logroscino

Full Professor

University Aldo Moro

ITALY

João Massano

Faculty of Medicine of the University of Porto

PORTUGAL

Ettore Beghi

Head Laboroatory of neurological Disorders

Istituto di Ricerche Farmacologiche Mario Negri IRCCS

ITALY

How do I reach out?

Meet Kite AI